Vida Health Secures $30 Million Funding to Expand Nationwide Virtual Care Platform Focused on Chronic Disease Prevention and Management

VCBeat (WeChat ID: vcbeat) learned from foreign media that on June 19, U.S. local time, healthcare company Vida Health completed a $30 million financing round. The proceeds from this round will be used to expand Vida Health’s nationwide adjunctive therapy network, enabling the company to attract more customers in the field of chronic disease management.

It is reported that this round of financing was jointly invested by GuideWell Connect, Teladoc, and Workday Ventures.

Vida Health, established in 2014 and headquartered in California, USA, is a healthcare company dedicated to providing personalized health plans for its clients.

In the United States, 40% of adults suffer from two or more chronic diseases, over 68% of adults experience mental health issues, and 43% of individuals with depression also have obesity. These conditions have gradually become among the most prevalent diseases afflicting humanity, following cancer and other major illnesses.

Following the completion of its previous funding round, Vida Health launched an optimized platform for its clients, providing personalized treatment plans for patients with anxiety, asthma, chronic obstructive pulmonary disease (COPD), depression, diabetes, hypertension, hyperlipidemia, and prediabetes.

Vida Health is dedicated to helping customers treat diseases at an early stage. When customers use the Vida Health platform, the company regularly collects various health data indicators, analyzes them, and provides feedback on their health status. When signs of illness appear, the platform prompts customers to seek care at professional medical institutions.

Furthermore, patients can communicate directly with healthcare professionals via text, voice, or real-time video to thoroughly discuss their medical conditions. Upon completion of the online consultation, healthcare providers will issue electronic prescriptions based on the patient’s condition. Patients may then order medications directly through the platform or purchase them independently at a pharmacy.

“Pat Geraghty, President and CEO of GuideWell Connect, stated, ‘When we first sought a partner for our commercial insurance business, our goal was to find a company capable of meeting the needs of the entire population and delivering personalized solutions to customers worldwide. As a virtual chronic care platform that integrates professional care teams with internet technology, Vida Health is the partner we have long been seeking. We look forward to collaborating with them to create value for our shareholders.’”

Workday Ventures, established in 2015 and headquartered in California, USA, is a venture capital firm dedicated to investing in companies at early and late growth stages, having completed 24 investments to date.

Teladoc, founded in 2002 and headquartered in New York, USA, is a company dedicated to the development of virtual healthcare services. The company is listed on the New York Stock Exchange under the ticker symbol TDOC.

GuideWell Connect, headquartered in Florida, USA, is a health solutions provider dedicated to delivering comprehensive medical services and helping customers manage their health scientifically.

(Compiled by Liu Yujing)